Sebben M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285 - Dumuis_1992_Naunyn.Schmiedebergs.Arch.Pharmacol_345_264
Author(s) : Dumuis A , Gozlan H , Sebben M , Ansanay H , Rizzi CA , Turconi M , Monferini E , Giraldo E , Schiantarelli P , Ladinsky H , et al.
Ref : Naunyn Schmiedebergs Arch Pharmacol , 345 :264 , 1992
Abstract : Dumuis_1992_Naunyn.Schmiedebergs.Arch.Pharmacol_345_264
ESTHER : Dumuis_1992_Naunyn.Schmiedebergs.Arch.Pharmacol_345_264
PubMedSearch : Dumuis_1992_Naunyn.Schmiedebergs.Arch.Pharmacol_345_264
PubMedID: 1320204

Title : Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain - Dumuis_1991_Naunyn.Schmiedebergs.Arch.Pharmacol_343_245
Author(s) : Dumuis A , Sebben M , Monferini E , Nicola M , Turconi M , Ladinsky H , Bockaert J
Ref : Naunyn Schmiedebergs Arch Pharmacol , 343 :245 , 1991
Abstract : Dumuis_1991_Naunyn.Schmiedebergs.Arch.Pharmacol_343_245
ESTHER : Dumuis_1991_Naunyn.Schmiedebergs.Arch.Pharmacol_343_245
PubMedSearch : Dumuis_1991_Naunyn.Schmiedebergs.Arch.Pharmacol_343_245
PubMedID: 1650917